patient cohort


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

patient cohort

1. Any group of individuals affected by common diseases, environmental or temporal influences, treatments, or other traits whose progress is assessed in a research study.
2. Any research subjects who are linked because they have something in common and who are then studied over time.
See also: cohort
References in periodicals archive ?
To generate sufficient numbers of patients in both PSA groups, we combined the 2 patient cohorts presented in Fig.
We could not be more pleased to have now completed the second, higher-dose patient cohort in both of our U.
DSMB support received to proceed to third patient cohort (n=4, dose level 2)
as seen most recently with last week's announcement of treatment of the second patient in the second patient cohort of our U.
CHICAGO -- The mean prevalence of dementia seen 2 years before a patient cohort began dialysis nearly quadrupled at 2 years after they began dialysis, Dr.
ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the fifth patient, the second in the second patient cohort, in its U.
Top line results from the Type II patient cohort indicate that ifetroban was overall well tolerated with no safety concerns noted.
The greatest mean decrease in HCV RNA from baseline was demonstrated in the patient cohort that received 1500 mg twice-daily, the highest dose of R7128 administered in the study.
ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Data and Safety Monitoring Board (DSMB), an independent group of medical experts closely monitoring the Company's three ongoing clinical trials, has authorized the Company to move forward with enrollment and treatment of second and third additional patients with Stargardt's macular dystrophy (SMD) in the second patient cohort of its U.
In-stent restenosis (reblockage in the stented area) results were 7 percent for the CYPHER(R) Stent patient cohort vs.
ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the final patient in the first patient cohort in its Phase 1/2 clinical trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).
Largest patient cohort (456 patients) with longest follow-up (average of 558 days)

Full browser ?